849-012
A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
More Information
NB-ND021 (NM21-1480)-101
A Phase 1/2 Study of NM21-1480 (Anti-PDL-1/Anti-4-1BB/Anti-HSA Tri-Specific Antibody) in Adult Patients with Advanced Solid Tumors
More Information
FPI-1966-101
A Phase 1/2 Study of [225Ac]-FPI-1966, [111In]-FPI-1967, and Vofatamab in Participants with FGFR3-expressing Advanced, Inoperable, Metastatic and/or Recurrent Solid Tumours
More Information
SWOG S1933
A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status
More Information
TCBIO-001-0710
The Caris Biorespository Research Protocol
More Information
